Tag:
Puerto Rico
Latest Headlines
Latest Headlines
Patheon exiting most manufacturing at U.K. plant
The company also plans to move to other facilities most of its product development work at Swindon that requires commercialization.
Pfizer workers at manufacturing hub sue over whiplashed retirement plans
Pfizer ( $PFE ) employees at the company's manufacturing hub in Puerto Rico are not happy with what company shenanigans did to Pfizer's stock price and to their retirement plans. They allege in...
FDA warns Mylan on PR plant violations
The FDA has warned Mylan ( $MYL ) of "significant violations" of manufacturing rules at a plant in Caguas, Puerto Rico, where inspectors found the drugmaker failed to properly test for product
Baxter faces land contamination suit in PR
A family that leased land for 18 years to drug- and devicemaker Baxter International near a Puerto Rican facility is now suing the company for $50 million, alleging the land is contaminated. The
Medtronic to create 200 jobs in PR
Medtronic plans to add roughly 200 jobs and put $50 million into the expansion of its Juncos operation in Puerto Rico over the next three years. The expansion and jobs come as the device giant's
Study finds quality risk gap between U.S., Puerto Rico plants
Location apparently does matter to drug quality risk after all. Even though pharma companies may be able to produce their meds more cheaply offshore than on, "substantial evidence" shows the quality
Study: Quality problems more common at offshore plants
There's a reason why so many pharma plants in Puerto Rico have drawn manufacturing warnings from the FDA, a new study suggests. Researchers found drugs made in offshore plants are more likely to have
GSK to pay $40.75M to settle case involving P.R. plant
GlaxoSmithKline and its SB Pharmco Puerto Rico unit have agreed to pay $40.75 million to 37 states and the District of Columbia over allegations of violating drug manufacturing standards. In a
Issa accuses FDA of lax J&J oversight
A Republican congressman is accusing the FDA of failing to keep a close enough eye on Johnson & Johnson's troubled Puerto Rico factory. Rep. Darrell Issa, who chairs the House Committee on
J&J's Cordis unit hit with warning letter on stents
Johnson & Johnson's woes just won't end. The company's Cordis unit has received a warning letter dated Feb. 16 for problems at a stent plant in Puerto Rico resulting from an inspection that took
